Xiao-Hong Wei Selected Research

salvianolic acid

1/2019	Total Salvianolic Acid Injection Prevents Ischemia/Reperfusion-Induced Myocardial Injury Via Antioxidant Mechanism Involving Mitochondrial Respiratory Chain Through the Upregulation of Sirtuin1 and Sirtuin3.
11/2010	Total salvianolic acid improves ischemia-reperfusion-induced microcirculatory disturbance in rat mesentery.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiao-Hong Wei Research Topics

Disease

10	Ischemia 06/2022 - 04/2010
8	Edema (Dropsy) 06/2022 - 10/2012
6	Reperfusion Injury 01/2021 - 01/2013
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 04/2010
4	Cardiomegaly (Heart Hypertrophy) 01/2021 - 01/2012
4	Fibrosis (Cirrhosis) 01/2019 - 01/2012
3	Body Weight (Weight, Body) 01/2019 - 01/2012
3	Myocardial Infarction 01/2018 - 04/2010
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2021 - 01/2019
2	Rupture 01/2021 - 09/2013
2	Lung Injury 01/2018 - 11/2014
2	Infarction (Infarctions) 10/2012 - 04/2010
1	Infections 06/2022
1	Chronic Pain 12/2020
1	Substance-Related Disorders (Drug Abuse) 12/2020
1	Endotoxemia 01/2019
1	Fatigue 01/2019
1	Hypertrophy 01/2019
1	Acidosis 01/2019
1	Hyperlipidemias (Hyperlipidemia) 01/2018
1	Cognitive Dysfunction 01/2018
1	Non-alcoholic Fatty Liver Disease 07/2017
1	Necrosis 01/2017
1	Ventricular Tachycardia 01/2017
1	Acute Kidney Injury (Acute Renal Failure) 01/2017
1	Cardiac Arrhythmias (Arrythmia) 01/2017
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2017
1	Acute Lung Injury 11/2014
1	Hypotension (Low Blood Pressure) 11/2014
1	Tachycardia (Tachyarrhythmias) 11/2014
1	Respiratory Tract Diseases (Respiratory Tract Disease) 10/2014
1	Cardiovascular Abnormalities 04/2014
1	Angina Pectoris 01/2013
1	Hypertension (High Blood Pressure) 01/2013
1	Colitis 01/2013

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 06/2022 - 04/2010
7	Adenosine Triphosphate (ATP)IBA 06/2022 - 01/2013
6	AlbuminsIBA 06/2022 - 10/2012
6	qishen yiqiIBA 01/2019 - 01/2012
4	Evans Blue (Blue, Evans)FDA Link 01/2019 - 10/2012
4	Adenosine Monophosphate (AMP)IBA 01/2018 - 01/2013
3	Pharmaceutical PreparationsIBA 12/2020 - 11/2008
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2019 - 01/2013
3	LipopolysaccharidesIBA 01/2019 - 11/2014
3	CytokinesIBA 01/2018 - 10/2014
3	Adenosine Diphosphate (ADP)IBA 01/2018 - 09/2013
3	CollagenIBA 04/2014 - 01/2012
3	Cardiotonic Agents (Cardiac Stimulants)IBA 01/2013 - 04/2010
2	astragaloside AIBA 06/2022 - 11/2013
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2021 - 06/2015
2	Connexin 43 (Connexin43)IBA 01/2021 - 01/2019
2	AntioxidantsIBA 01/2019 - 06/2015
2	Sirtuin 3IBA 01/2019 - 01/2017
2	salvianolic acidIBA 01/2019 - 11/2010
2	Claudin-5IBA 01/2018 - 10/2012
2	OccludinIBA 01/2018 - 10/2012
2	Nonesterified Fatty Acids (NEFA)IBA 07/2017 - 01/2013
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2013 - 04/2010
1	Small Interfering RNA (siRNA)IBA 06/2022
1	notoginsenoside R1IBA 01/2021
1	Electron Transport Complex I (NADH-CoQ Reductase)IBA 01/2021
1	oligomycin sensitivity-conferring protein (complex V)IBA 01/2021
1	SirtuinsIBA 01/2021
1	Actins (F Actin)IBA 01/2021
1	rho-Associated KinasesIBA 01/2021
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 12/2020
1	Analgesics (Analgesic Drugs)IBA 12/2020
1	Opioid Analgesics (Opioids)IBA 12/2020
1	SodiumIBA 01/2019
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2019
1	Sirtuin 1IBA 01/2019
1	Hematoxylin (Haematoxylon)IBA 01/2019
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2019
1	ChemokinesIBA 01/2019
1	Insulin (Novolin)FDA Link 01/2019
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2019
1	ribosomal protein S19IBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	Silybin (Lagosa)IBA 01/2018
1	schizandrinIBA 01/2018
1	Keratins (Keratin)IBA 01/2018
1	gualou xiebai baijiutangIBA 01/2018
1	von Willebrand FactorIBA 01/2018
1	oxidized low density lipoproteinIBA 01/2018
1	CalciumIBA 01/2017
1	Methyl ester 1,4- dihydro- 2,6- dimethyl- 5- nitro- 4- (2- (trifluoromethyl)phenyl)- 3-Pyridinecarboxylic acidIBA 01/2017
1	Urea (Carbamide)FDA LinkGeneric 01/2017
1	eleclazineIBA 01/2017
1	CreatinineIBA 01/2017
1	Cisplatin (Platino)FDA LinkGeneric 01/2017
1	NADH DehydrogenaseIBA 06/2015
1	andrographolideIBA 11/2014
1	Messenger RNA (mRNA)IBA 11/2013
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2013
1	Sulfonic AcidsIBA 01/2013
1	Huang QiIBA 01/2013

Therapy/Procedure

5	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2021 - 10/2014
4	Therapeutics 12/2020 - 11/2008
2	Lasers (Laser) 01/2013 - 01/2012
1	Electroacupuncture 04/2014